Published online Feb 19, 2024. doi: 10.5498/wjp.v14.i2.287
Peer-review started: September 29, 2023
First decision: December 6, 2023
Revised: December 25, 2023
Accepted: January 19, 2024
Article in press: January 19, 2024
Published online: February 19, 2024
Processing time: 129 Days and 21 Hours
Depression in cancer patients should be identified since it may lower survival rates and indicate early death. When anxiety and depression are present, treatment for depression and cancer might become more difficult and treatment compliance issues can make matters worse.
Cancer patients are more likely to experience psychological distress, and medical professionals fail to recognize cancer patients who are depressed and anxious, which results in inadequate treatment.
To assess the prevalence of depression and anxiety among cancer patients in a tertiary cancer center.
A cross-sectional study was conducted among 220 cancer patients by convenience sampling of patients attending a tertiary cancer hospital. We used a face-to-face interview technique to collect the data by using the standard tool Patient Health Questionnaire (PHQ-9) for depression and the Hospital Anxiety and Depression sub-scale for anxiety. Simple descriptive analysis was performed by categorizing the depression and anxiety according to the score.
Most of the cancer patients had depression and one-third had anxiety. Among the respondents, 124 (56.4%) had mild depression, 70 (31.8%) had moderate depression, and 3 (1.3%) had severe depression; 79 (35.9%) had mild anxiety, 64 (29.1%) had moderate anxiety, and 4 (1.8%) had severe anxiety. It is noteworthy that 77 (43.8%) of the depressed patients were diagnosed with third-stage, followed by 58 (33.0%) with second-stage cancer, and 64 (43.5%) anxious patients with third-stage cancer.
Most of the cancer patients had depression and about one-third had anxiety which was high in third-stage cancer.
The prevalence of depression and anxiety was higher than in other studies. Our findings highlighted the necessity of counseling services parallel to cancer therapy.
